OBJECTIVES: Cardiac surgery is associated with elevated bleeding risk. We sought to study whether fibrin clot phenotype influences postoperative blood loss after surgery for aortic stenosis (AS).
INTRODUCTION
Up to 15% of procedures requiring cardiopulmonary bypass (CPB) are complicated by postoperative haemorrhage [1, 2] . Excessive postoperative bleeding negatively affects morbidity and mortality in cardiosurgical patients [3] . The occasionally inevitable re-exploration for bleeding dramatically increases postoperative mortality rates and adversely affects outcomes [4] . Early postoperative blood loss after open heart surgery may be secondary to surgical factors, platelet dysfunction and/or loss secondary to CPB exposure, drug-induced impairment of platelet aggregation or coagulation factor deficiencies [2, 5, 6] .
Despite enormous progress in the perioperative management of cardiac surgery, identifying the subjects who are at risk of postoperative bleeding remains challenging. Routine coagulation tests fail to identify patients who are at high risk of excessive postoperative drainage [2, 7] .
Several bleeding risk scores have been developed for patients undergoing cardiac surgery, including the Papworth Bleeding Risk Stratification Score [8] , which lists any aortic valve (AV) disease [whether aortic stenosis (AS) or regurgitation] as a risk factor for bleeding. Degenerative AS is common in developed countries, and its prevalence increases with age [9] . There may be a bleeding tendency in AS driven by an imbalance in von Willebrand factor (VWF) high molecular weight multimers [10] .
Blood coagulation leads to thrombin-mediated conversion of fibrinogen to fibrin. Fibrin clots composed of tightly packed thin fibres with small pores between them are relatively resistant to lysis [11] , and this prothrombotic clot phenotype has been shown to be involved in multiple disease states, such as myocardial infarction [12] , ischaemic stroke [13] and venous thromboembolism [14] ; however, the data on the associations of these clot properties with haemorrhagic states are scarce. It has been reported that haemophilia A and B are characterized by the presence of fibrin clots composed of thick fibrin fibres that are susceptible to fibrinolysis [15] . Increased fibrin clot permeability and susceptibility to lysis is also associated with heavy menstrual bleeding in patients without any known organic or haemostatic abnormalities [16] . In 2010, we showed that shorter preoperative clot lysis time (CLT), indicating faster fibrinolysis, was associated with increased mediastinal drainage in patients undergoing elective coronary artery by-pass grafting (CABG) [17] . The hypothesis that a haemorrhagic clot phenotype may be associated with surgical bleeding after valvular surgery has not been investigated to date. We hypothesized that in AS patients undergoing surgical AV replacement (AVR), a fibrin clot with a fibrinolysis-susceptible phenotype, characterized by a short CLT, would predispose patients to increased postoperative blood loss. Parameters reflecting fibrin clot properties were studied, along with tests assessing the fibrinolytic system, thrombin generation, VWF and platelet activity, as well as tissue factor (TF). The relationship of these parameters to postoperative blood loss was investigated.
MATERIALS AND METHODS

Patients
From June 2014 to October 2015, we enrolled patients scheduled for elective surgery due to AS. We excluded patients who needed revascularization or who had a history of an acute cardiovascular event within 3 months prior to enrolment; those with rheumatic disease, left ventricular ejection fraction <30%, history of autoimmune disease or cancer, liver failure with alanine aminotransferase >62 U/l, renal failure with creatinine >177 mmol/ l; and those treated with any anticoagulant or antiplatelet drug other than aspirin or acute illness [18] . All patients were euthyroid [19] and in normal sinus rhythm. AS was the primary indication for surgery, and post-stenotic aortic dilation was not an exclusion criterion. The study was performed in accordance with the Declaration of Helsinki and received approval from the Jagiellonian University Ethical Committee. All patients provided their written informed consent. The primary end points in this study were postoperative blood loss after 6, 12 and 24 h.
Aortic valve replacement
All patients underwent surgery through a full median sternotomy (AVR) or ministernotomy with CPB, which was performed at moderate hypothermia (oesophageal temperature 32 C) using a non-pulsatile roller pump and a 40-lm arterial blood filter (both, Jostra Medizintechnik AG, Hirrlingen, Germany) with blood flow of 2.0-2.4 l/min/m 2 and mean arterial pressure of 40-60 mmHg. If the dilation of the ascending aorta or aortic root was confirmed intraoperatively (>45 mm), the Bentall procedure was executed. Anticoagulation was achieved by administering heparin (300 IU/kg) before the onset of CPB and monitored using the activated clotting time (>480 s during CPB, and normal after reversal by protamine at the end of CPB). Heparin was also present in the CPB prime solution (10 000 IU). All procedures were performed by 11 experienced surgeons, who had performed over 100 procedures yearly, and scrupulous surgical haemostasis was strived for in all cases. None of the patients received aminocaproic acid, aprotinin or desmopressin acetate, and 'cell-savers' were not used. Tranexamic acid was administered in 2 doses (20 mg/kg i.v. after sternotomy and 20 mg/kg i.v. after the end of CPB) in all cases. Indications for transfusions are presented in Fig. 1 [20] . Whether to administer an intraoperative platelet transfusion was a decision made by the surgeon with the anaesthesiologist on a case-by-case basis when diffuse tissue oozing that could not be controlled by surgical measures was noted (Fig. 1) . The pleural space was not opened or drained.
Postoperative management
All patients were transferred to the intensive care unit (ICU) for postoperative ventilation and extubated following standard criteria. Indications for transfusion and rethoracotomy are presented in Fig. 1 . The total number of units of transfused blood products was recorded. The volume of postoperative drainage was recorded after 6, 12 and 24 h postoperatively. Drained blood was never reinfused.
Laboratory investigations
Fasting blood samples were collected from an antecubital vein with minimal stasis at 6-8 AM on the day of surgery. After centrifugation, the supernatant was stored at -20 C until it was assayed. Plasma samples were centrifuged, frozen and stored in aliquots at -80 C until they were assayed. Fibrinogen was determined using the Clauss method. Highsensitivity C-reactive protein was measured by latex nephelometry (Siemens, Marburg, Germany). VWF antigen was measured by an immunoturbidimetric method (Siemens, Erlangen, Germany). VWF activity (ristocetin cofactor activity) was determined turbidimetrically (Siemens, Erlangen, Germany). The normal reference ranges for VWF antigen and activity are 58-174% and 58-172%, respectively.
Plasma plasminogen activator inhibitor-1 (PAI-1) levels and activity were measured by ELISAs (Technozym, Diapharma, West Chester, OH, USA). TF activity was measured by a chromogenic assay (ACTICHROME V R TF activity assay, Sekisui Diagnostics, Lexington, MA, USA). TF antigen was measured by ELISA (IMUBIND V R , Sekisui Diagnostics, Lexington, MA, USA). We also measured activated and inactivated thrombin-activatable fibrinolysis inhibitor (TAFI) antigen in plasma (TAFIa/TAFIai; Diagnostica Stago, Asnieres, France). Plasma platelet activation marker, soluble CD40 ligand (sCD40L) and b-thromboglobulin were assessed by ELISAs (R&D Systems, Minneapolis, MN, USA). All measurements were performed by technicians who were blinded to the sample origin.
Thrombin generation
The measurement of thrombin generation was performed using calibrated automated thrombography (Thrombinoscope BV, Maastricht, the Netherlands). A detailed description can be found in the Supplementary Material Section 'Thrombin generation'.
Fibrin clot analysis
Plasma fibrin clot variables were determined at least in duplicate (for all variables, the intra-assay and interassay coefficients of variation ranged from 5% to 8%). The plasma fibrin clot permeability was determined in a hydrostatic pressure system as described previously [14] . A permeation coefficient (K s ), reflecting pore size, was calculated from the following equation: K s = (QÂLg)/(tÂAÂDp), where Q is the flow rate in time t, L is the length of a fibrin gel, g is the viscosity of liquid, A is the crosssectional area and Dp is a differential pressure in dyne/cm 2 . Lower K s values indicate reduced permeability.
Fibrinolysis induced by recombinant tPA, which was expressed as the CLT, was measured using a TF-induced clot lysis assay, as previously described [21] . A detailed description can be found in the Supplementary Material Section 'Fibrin clot analysis'.
Statistical analysis
Continuous variables were evaluated for a normal distribution with the Shapiro-Wilk test. Data are expressed as the mean ± standard deviation or median (interquartile range) unless otherwise stated. To assess the differences between 2 continuous variables, the Student's t-test (for normally distributed values) or the Mann-Whitney U-test (for non-normally distributed values) was applied. Categorical variables (expressed as a number and a percentage) were compared by the v 2 test or Fisher's exact test (when any of the expected cell frequencies was <5). Pearson's correlation coefficient or Spearman's rank correlation coefficient was calculated to assess the linear correlations between variables with a normal or non-normal distribution, respectively. We used the drainage volume after 12 h for analyses, based on the Universal Definition of Perioperative Bleeding in Cardiac Surgery (UDPB) [22] . Predictors of being in the highest 12-h drainage quartile were identified in the logistic regression analysis (variables with P < 0.1 in the univariable analysis were entered into the multiple model). A strong significant correlation between any 2 parameters (r > 0.5) excluded one of the parameters from the multiple logistic regression models, except for fibrinogen, which 
RESULTS
Patient characteristics
A total of 77 patients with severe AS, who were mostly overweight, hypertensive and hypercholesteraemic men on aspirin and statins with normal left ventricular function and a median age of 68 years were recruited into the study ( Table 1 ). The surgical characteristics are presented in Table 2 . A ministernotomy was performed in 11 AVR cases (14%), and the Bentall procedure was performed in 15 cases (19%, all through a full sternotomy). According to the Papworth Bleeding Risk Score [8] , the vast majority of patients belonged to the medium-bleeding-risk group (n = 74, 96%), while only 3 patients belonged to the high-risk group (4%).
Baseline fibrin and fibrinolysis parameters
The baseline values of fibrin characteristics, along with fibrinolysis inhibitors, thrombin generation, TF, VWF and platelet activity, are presented in Table 3 . Both the K s and CLT were correlated with fibrinogen (r = -0.78, P < 0.0001 and r = 0.43, P = 0.0001, respectively) and C-reactive protein (r = -0.50, P < 0.000 and r = 0.42, P = 0.0002, respectively). The K s and CLT were also associated with the PAI-1 antigen level (r = -0.36, P = 0.002 and r = 0.56, P < _ 0.0001, respectively) and activity (r = -0.26, P = 0.03 and r = 0.58, P < _ 0.0001, respectively). 
Thrombin generation
Peak thrombin generation was positively correlated with TF activity (r = 0.32, P = 0.004). TF activity was also inversely correlated with the ttPeak (r = -0.33, P = 0.004). In terms of fibrin properties, there was a positive correlation between the CLT and ETP (r = 0.31, P = 0.006). Baseline platelet activity, von Willebrand factor and tissue factor
Platelet count was normal in all subjects (Table 3 ) and was correlated not only with sCD40L (r = 0.26, P = 0.02) and TF activity (r = 0.31, P = 0.006) but also with the K s and CLT (r = -0.28, P = 0.02 and r = 0.26, P = 0.02, respectively). No correlation with b-thromboglobulin was found. Both VWF antigen and activity were inversely correlated with the K s (r = -0.40, P = 0.0006 and r = -0.35, P = 0.004, respectively) and positively correlated with peak thrombin generation (r = 0.27, P = 0.03 and r = 0.26, P = 0.03, respectively).
Postoperative outcomes
Postoperative blood loss after 6, 12 and 24 h ( Table 2 ) was independent of the preoperative use of aspirin, platelet count, activated partial thromboplastin time, international normalized ratio and VWF, CPB time or sternotomy type (full versus ministernotomy); however, males had higher drainage volumes than females (+32% after 6 h, P = 0.009; +34% after 12 h, P = 0.002; and +56% after 24 h, P = 0.0004). Three re-explorations for bleeding were performed after isolated AVR (5% of AVR patients) and 3 others were performed after the Bentall procedure [20% of this subset of patients; P = 0.049 (Fisher's exact test)]. The associations between chest tube output and preoperative fibrin clot properties, as well as the other parameters, are presented in Table 3 and  Supplementary Material, Table S1 . Patients with drainage in the top quartile after 12 h (> _600 ml) were less frequently men (10 vs 59%, respectively, P = 0.001) and had a higher rate of rethoracotomy for bleeding (25 vs 0%, respectively, P = 0.02), lower fibrinogen, shorter CLT, higher K s , lower PAI-1 antigen, peak thrombin generation and b-thromboglobulin levels than those in the lowest drainage quartile (< _260 ml) ( Table 3) .
Patients who underwent the Bentall procedure had higher postoperative drainage after 6 h (+150%, P = 0.0005), 12 h (+117%, P < 0.0001) and 24 h (+86%, P < 0.0001) than AVR-only patients. According to the UDPB [22] , 15 patients (19%) had severe bleeding, including 9 patients who underwent AVR (15%) and 6 patients who underwent the Bentall procedure [40%; P = 0.038 (Fisher's exact test) ].
Analyses after exclusion of patients who underwent the Bentall procedure
Because patients who underwent the Bentall procedure appeared to bleed excessively, we repeated the analyses in patients who underwent AVR only (n = 62) to evaluate the correlation between the CLT (Fig. 2) Table S2 ). Finally, the CLT was inversely correlated with the number of transfused platelet units [r = -0.26, P = 0.03 in all patients (n = 77) and r = -0.27, P = 0.04 in the AVRonly subset (n = 62)]. The studied parameters were not associated with the time to extubation or ICU length of stay.
DISCUSSION
This study reports for the first time that fibrin clot susceptibility to lysis is a predictor of postoperative blood loss after surgery for AS, even if preoperative fibrinogen levels are normal.
Ranucci et al. [23] reported that fibrinogen level on admission to the ICU was associated with postoperative bleeding in cardiac surgery. In a thromboelastographic study of 445 patients who underwent heart surgery and had low platelet counts following 
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CPB cessation, the same group recently reported that higher fibrinogen levels (>2.4 g/l) compensated for clot firmness in thrombocytopaenia and effectively reduced blood loss [24] . In our cohort, the preoperative fibrinogen levels were normal but were inversely correlated with chest tube output. Whether fibrinogen is low preoperatively or is lost during surgery, a low fibrinogen makes the patient more likely to bleed in the ICU. Our study, however, points to the crucial role of the fibrin network, which is formed from fibrinogen. Formation of the fibrin network is essential for haemostasis. It is initiated by limited proteolysis of fibrinogen by thrombin, with the thrombin-mediated conversion of plasma fibrinogen into fibrin, and the formation of clots that are relatively resistant to lysis. The fibrinogen concentration is recognized as one of the main modulators of fibrin structure. In our AVR cohort, the CLT predicted higher postoperative blood loss, and it was associated with platelet transfusions. One might speculate that a shorter preoperative CLT may help in identifying patients who are prone to bleeding following AVR.
The role of fibrin is well established in thrombotic disease [11] [12] [13] [14] ; however, the association between fibrin properties and bleeding complications is largely unexplored. In 2015, in a study on 52 women, our group found an association between a shorter CLT and heavy menstrual bleeding that could not otherwise be explained [16] ; and earlier, in 2010, we reported that the CLT was associated with total drainage after CABG [17] . To date, there have been no reports regarding the association between fibrin properties and surgical bleeding after a valvular surgery. A recent meta-analysis involving 1035 surgical patients showed that a fibrinogen concentrate transfusion was associated with reduced bleeding [25] . An intriguing question arises: What influence would external fibrinogen delivery have on fibrin clot properties? In our study, none of the patients received a fibrinogen transfusion; however, prolongation of the CLT might be suspected. It is also not known whether individuals with the shortest CLT would benefit from less invasive approaches.
Furthermore, we have previously demonstrated that in patients who underwent CABG, a lower preoperative VWF activity contributed to increased postoperative bleeding [2] . In AS, there might be a bleeding tendency driven by an imbalance in VWF [10] . This prompted us to exclude the confounding effect of VWF on the current results. Although there was an expected association of VWF with K s , no influence of VWF was found on postoperative drainage. On the other hand, platelet activation was associated with chest tube output. Not only was b-thromboglobulin inversely correlated with drainage but it also (along with the fibrinogen concentration and CLT) predicted higher blood loss after 12 h.
Furthermore, calibrated automated thrombography was used in 2013 by Bosch et al. [26] to show that lower values of the maximum amount of thrombin formed (peak thrombin) were independently correlated with higher postoperative chest tube drainage after cardiac surgery. Our results are in accordance with this report, showing an inverse correlation between postoperative blood loss and peak thrombin. In addition, TF activity, which contributes to thrombin generation [27] , was correlated with peak thrombin generation and blood loss in the current study.
The well-documented role of fibrinolysis in postsurgical haemostasis deserves commentary. Lower levels of PAI-1, which result in less inhibition of fibrinolysis, are known to be associated with enhanced bleeding after cardiac surgery [28] . Lower PAI-1 antigen was also associated with higher early blood loss in the current study. Although TAFI did not affect bleeding in the current report, other fibrinolysis modulators that were not studied might have been of some importance. The inhibition of fibrinolysis is a target of therapeutic interventions in cardiac surgery [29] .
Limitations
The number of studied patients is limited, so multivariable analyses should be interpreted with caution. A fraction of patients (60%) were on aspirin until the day of surgery, which is a risk factor for bleeding; however, this did not influence the postoperative blood loss whatsoever. Patients with AS who had a dilated ascending aorta and required the Bentall procedure appeared to bleed excessively in this study, which might be related to surgical factors. Operative procedures by different surgeons might have influenced the results, and a surgical component is a potential source of bias. Blood product transfusions were not the primary outcome measure in this study.
CONCLUSIONS
In conclusion, preoperative fibrin clot susceptibility to fibrinolysis is a modulator of postoperative blood loss after cardiac surgery for AS, and it affects the postoperative rate of platelet transfusion. The CLT may become a tool to preoperatively stratify bleeding risk in the future.
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